Drug Details
Olumiant (Baricitinib) is a type of drug known as a janus kinase, or JAK, inhibitor, which generally works by blocking proteins that play a role in inflammation.
Study Purpose
Multiple studies are taking place involving this drug. The reason for the studies is to see if the study drug baricitinib is effective in hospitalized participants with COVID-19.
